PharmaCorp Acquires Pharmacy in Western Canada

PharmaCorp Rx Inc., a growing entity listed on the TSX Venture Exchange, has reached a definitive agreement to acquire a pharmacy based in Western Canada from independent vendors for $2.4 million. This acquisition aligns with PharmaCorp's strategic alliance with PharmaChoice Canada and underscores its commitment to expanding its operations across the country. The transaction, set to close by July 31, 2025, will be financed using existing cash resources and is subject to the typical closing conditions. No finder’s fee will be associated with this acquisition. This move is emblematic of PharmaCorp's broader strategy to enhance its platform via acquisitions, including both PharmaChoice branded and independently owned pharmacies. Alan Simpson, the Executive Chair of PharmaCorp, has emphasized the continued search for growth opportunities within the market, buoyed by strategic partnerships and market conditions. The forward-looking statements in the announcement reflect optimism in future deals and an accelerated growth trajectory for the company's pharmacy operations.